younes Oujidi
Berkane, 9999, Morocco
NCT Number: NCT04995289
Introduction:
The main manifestation of COVID-19 pneumonia is acute respiratory distress syndrome (ARDS), which in some cases can be more severe than intubation, extracorporeal membrane venous oxygenation (VV-ECMO) to ensure hematosis. Despite support from VV-ECMO, some patients may remain hypoxemic. One possible therapeutic procedure for these patients is the application of the prone position.
Objective:
The main aim of this study was to investigate the modification of the PaO2/FiO2 ratio, the compliance of the respiratory system in VV-ECMO with refractory hypoxemia. The secondary objective was to evaluate the safety and feasibility of the inclined position for ECMO.
Methods:
the investigators reviewed the electronic records and lists of all 23 COVID-19 patients. were placed for the first time in PP with an average duration of 16 h . patient characteristics, pre-ECMO characteristics, ventilator/ECMO settings, and changes in ventilator/ECMO settings and blood gas analysis before and after PP.
Looking for future studies?
Notify MeAll sexes
Observational
Berkane, 9999, Morocco
The main objective of the current study was to investigate the change in PaO2/FiO2 ratio, the compliance of the respiratory system in VV-ECMO patients with persistent hypoxemia. Measurements were taken before PP, 1 h after the start of the PP, at the end of the PP cycle.
The secondary objective of this study was to assess the safety and feasibility of emergency positioning for patients with severe ARDS during ECMO treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
blood gas analysis before and after PP
Time frame: through study completion, an average of 1 yea
the investigators recoordeed Blood gas analysis before and after Prone position
Mohammed VI University Hospital
Other
Prone Position During ECMO in Covid Hypoxaemic Patient :A PROCESS-compliant Case Series From the Eastern Morocco
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06633835
COVID-19, Coronaviridae Infections
Salt Lake City, Utah, United States
View Trial DetailsNCT06234956
COVID-19, Coronaviridae Infections
Barcelona, Spain
View Trial DetailsNCT07408297
COVID -19, COVID-19
Kisumu, Kenya
View Trial DetailsNCT06065176
COVID-19, Coronaviridae Infections
Salt Lake City, Utah, United States
View Trial Details